Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 6;8(3):rkae105.
doi: 10.1093/rap/rkae105. eCollection 2024.

High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease

Bernardo D'Onofrio  1 , Giulia Virelli  1 , Elisa Pedrollo  1 , Marta Caprioli  1 , Marta Riva  1 , Daniela Renna  1 , Antonio Tonutti  1   2 , Nicoletta Luciano  1   2 , Angela Ceribelli  1   2 , Elisa Gremese  1   2 , Maria De Santis  1   2 , Carlo Selmi  1   2
Affiliations

High risk of misclassification of acute Parvovirus B19 infection into a systemic rheumatic disease

Bernardo D'Onofrio et al. Rheumatol Adv Pract. .

Abstract

Objectives: Parvovirus B19 most frequently causes epidemics of erythema infectiosum in children but also affects adults often leading to rheumatologic manifestations. While the serum profile allows the diagnosis, manifestations may mimic autoimmune conditions. The aim was to evaluate the proportion of patients with acute Parvovirus B19 infection fulfilling classification criteria for rheumatic diseases (RA and SLE).

Methods: We evaluated the clinical and serological features of 54 patients diagnosed with acute Parvovirus B19 infection seeking rheumatological attention between March and June 2024.

Results: The majority of patients were females (78%), with a mean (s.d.) age of 45 (13) years and 54% could not recall any known exposure. Fifty-one/54 (94%) had arthralgia, 27 (50%) arthritis (oligoarthritis in 67% of them), 24 (44%) fever, 19 (35%) skin rash and 7 (13%) purpura. Symptoms resolution generally occurred within 6 weeks. Complement levels were low in 14/33 (42%) tested patients, while the presence of serum ANA, anti-dsDNA, anti-phospholipids and rheumatoid factor was detected in 21/38 (55%), 10/26 (38%), 6/12 (50%) and 5/37 (13%) patients, respectively. Classification criteria for SLE were fulfilled in 93% of ANA-positive patients and RA criteria in 38% of patients with arthritis.

Conclusions: Parvovirus B19 infection manifestations may vary and nearly all patients with positive serum ANA fulfil the classification criteria for SLE. The risk of misclassification in patients with viral infection should not be overlooked.

Keywords: RA; SLE; classification criteria; systemic autoimmune diseases; viral arthritis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Clinical and laboratory characteristics of patients fulfilling RA and SLE classification criteria. dsDNA: anti-dsDNA antibodies
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Lunardi C, Tinazzi E, Bason C. et al. Human parvovirus B19 infection and autoimmunity. Autoimmun Rev 2008;8:116–20. - PubMed
    1. Tzang B-S, Lee Y-J, Yang T-P. et al. Induction of antiphospholipid antibodies and antiphospholipid syndrome-like autoimmunity in naive mice with antibody against human parvovirus B19 VP1 unique region protein. Clin Chim Acta 2007;382:31–6. - PubMed
    1. Adiguzel Y, Mahroum N, Muller S. et al. Shared pathogenicity features and sequences between EBV, SARS-CoV-2, and HLA Class I molecule-binding motifs with a potential role in autoimmunity. Clin Rev Allergy Immunol 2023;65:206–30. - PubMed
    1. Saadoun D, Landau DA, Calabrese LH, Cacoub PP.. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology (Oxford) 2007;46:1234–42. - PubMed
    1. Stratton R, Slapak G, Mahungu T, Kinloch-de Loes S.. Autoimmunity and HIV. Curr Opin Infect Dis 2009;22:49–56. - PubMed

LinkOut - more resources